Kettle Hill Capital Management, LLC Nex Immune, Inc. Transaction History

Kettle Hill Capital Management, LLC

  • $340 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$0.6 - $17.5 $58,946 - $1.72 Million
98,244 Added 36.06%
370,691 $206,000
Q2 2022

Dec 08, 2022
BUY
$1.61 - $4.68 $438,639 - $1.28 Million
272,447 New
272,447 $439,000

About NexImmune, Inc.

NEXI Quotes by TradingView
  • Ticker NEXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,155,600
  • Market Cap $6.04M
  • Description
  • NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...
More about NEXI
Track This Portfolio

Track Kettle Hill Capital Management, LLC Portfolio

Follow Kettle Hill Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kettle Hill Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kettle Hill Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email